Headshot - Chris Mason

Christopher Mason, Ph.D., is an Associate Professor of Genomics at Weill Cornell Medicine, as well as the Director of the WorldQuant Initiative for Quantitative Prediction, with appointments at Memorial Sloan Kettering Cancer Center (MSKCC) and Rockefeller University.

The Mason laboratory develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and human physiology. The Mason laboratory creates and deploys novel techniques in next-generation sequencing and algorithms for: tumor evolution, genome evolution, DNA and RNA modifications, and genome/epigenome engineering. It also works closely with NIST/FDA to build international standards for these methods (SEQC2, IMMSA, and Epigenomics QC groups), to ensure clinical-quality genome measurements and editing. It also works with NASA to build integrated molecular portraits of genomes, epigenomes, transcriptomes, and metagenomes for astronauts, which help establish the molecular foundations and genetic defenses for enabling long-term human spaceflight.

Dr. Mason has won the NIH’s Transformative R01 Award, the NASA Group Achievement Award, the Pershing Square Sohn Cancer Research Alliance Young Investigator award, the Hirschl-Weill-Caulier Career Scientist Award, the Vallee Scholar Award, the CDC Honor Award for Standardization of Clinical Testing, and the WorldQuant Foundation Scholar Award.  He was named as one of the “Brilliant Ten” Scientists by Popular Science, featured as a TEDMED speaker, and called “The Genius of Genetics” by 92Y.  He has more than 175 peer-reviewed papers that have been featured on the covers of Nature, Science, Cell, Nature Biotechnology, Nature Microbiology, and Neuron, as well as cited by the U.S. District Court and U.S. Supreme Court.  Coverage of his work has also appeared on the covers of the Wall Street Journal, New York Times, TIME, The LA Times, and across many media outlets (ABC, NBC, CBC, CBS, Fox, CNN, PBS, NASA, NatGeo). He has co-founded five biotechnology start-up companies (Genome Liberty, Biotia, Onegevity Health, P-Omics, and Shanghai GeneTech) and serves as an advisor to 15 others. He lives with his daughter and wife in Brooklyn, NY.